Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 1.508
+0.012 (0.80%)
Mar 23, 2026, 1:59 PM CET
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 591.35 million as of March 23, 2026. Its market cap has increased by 84.93% in one year.
Market Cap
591.35M
Enterprise Value
658.32M
Revenue
71.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.51
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 591.35M, a decrease of -64.58%. That is a compound annual growth rate of -10.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 591.35M | -54.87% |
| Dec 30, 2025 | 1.31B | 291.35% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medivir AB | 1.16B |
| Xspray Pharma AB | 1.11B |
| Genovis AB (publ.) | 1.07B |
| Cantargia AB | 959.64M |
| SynAct Pharma AB | 945.31M |
| FluoGuide | 712.83M |
| Infant Bacterial Therapeutics AB | 649.32M |
| Corline Biomedical AB | 405.97M |